<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32586411</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2051-5960</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jun</Month><Day>26</Day></PubDate></JournalIssue><Title>Acta neuropathologica communications</Title><ISOAbbreviation>Acta Neuropathol Commun</ISOAbbreviation></Journal><ArticleTitle>Global alterations to the choroid plexus blood-CSF barrier in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>92</StartPage><MedlinePgn>92</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">92</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40478-020-00968-9</ELocationID><Abstract><AbstractText>The choroid plexus (CP) is a highly vascularized structure located in the ventricles that forms the blood-CSF barrier (BCSFB) and separates the blood from the cerebrospinal fluid (CSF). In addition to its role as a physical barrier, the CP functions in CSF secretion, transport of nutrients into the central nervous system (CNS) and a gated point of entry of circulating immune cells into the CNS. Aging and neurodegeneration have been reported to affect CP morphology and function and increase protein leakage from blood to the CSF. Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease associated with both upper and lower motor neuron loss, as well as altered proteomic and metabolomic signatures in the CSF. The role of the BCSFB and the CP in ALS is unknown. Here we describe a transcriptomic and ultrastructural analysis of BCSFB and CP alterations in human postmortem tissues from ALS and non-neurologic disease controls. ALS-CP exhibited widespread disruptions in tight junctional components of the CP epithelial layer and vascular integrity. In addition, we detected loss of pericytes around ALS blood vessels, accompanied by activation of platelet aggregation markers vWF and Fibrinogen, reminiscent of vascular injury. To investigate the immune component of ALS-CP, we conducted a comprehensive analysis of cytokines and chemokine panels in CP lysates and found a significant down-regulation of M-CSF and V-CAM1 in ALS, as well as up-regulation of VEGF-A protein. This phenotype was accompanied by an infiltration of MERTK positive macrophages into the parenchyma of the ALS-CP when compared to controls. Taken together, we demonstrate widespread structural and functional disruptions of the BCSFB in human ALS increasing our understanding of the disease pathology and identifying potential new targets for ALS therapeutic development.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saul</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, St. Joseph's Hospital and Medical Center and Barrow Neurological Institute, 350 W Thomas Road, Phoenix, AZ, 85013, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gregory W. Fulton ALS Center, Barrow Neurological Institute, Phoenix, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hutchins</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Neurogenomics Division, Translational Genomics Research Institute (Tgen), Phoenix, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reiman</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Neurogenomics Division, Translational Genomics Research Institute (Tgen), Phoenix, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saul</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Arizona State University, Tempe, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostrow</LastName><ForeName>L W</ForeName><Initials>LW</Initials><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>B T</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Departments of Pathology and Neurology, Georgetown University Medical Center, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Keuren-Jensen</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Neurogenomics Division, Translational Genomics Research Institute (Tgen), Phoenix, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowser</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, St. Joseph's Hospital and Medical Center and Barrow Neurological Institute, 350 W Thomas Road, Phoenix, AZ, 85013, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gregory W. Fulton ALS Center, Barrow Neurological Institute, Phoenix, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakkar</LastName><ForeName>N</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-4656-9337</Identifier><AffiliationInfo><Affiliation>Department of Neurobiology, St. Joseph's Hospital and Medical Center and Barrow Neurological Institute, 350 W Thomas Road, Phoenix, AZ, 85013, USA. Nadine.bakkar@dignityhealth.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gregory W. Fulton ALS Center, Barrow Neurological Institute, Phoenix, AZ, USA. Nadine.bakkar@dignityhealth.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Neuropathol Commun</MedlineTA><NlmUniqueID>101610673</NlmUniqueID><ISSNLinking>2051-5960</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001812" MajorTopicYN="N">Blood-Brain Barrier</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002831" MajorTopicYN="N">Choroid Plexus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015539" MajorTopicYN="N">Platelet Activation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Blood-CSF barrier</Keyword><Keyword MajorTopicYN="N">Choroid plexus</Keyword><Keyword MajorTopicYN="N">RNA sequencing</Keyword><Keyword MajorTopicYN="N">Tight junctions</Keyword></KeywordList><CoiStatement>RB is a founder of Iron Horse Diagnostics, Inc., a biotechnology company focused on diagnostic and prognostic biomarkers for ALS and other neurologic disorders.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32586411</ArticleId><ArticleId IdType="pmc">PMC7318439</ArticleId><ArticleId IdType="doi">10.1186/s40478-020-00968-9</ArticleId><ArticleId IdType="pii">10.1186/s40478-020-00968-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Annunziata P, Volpi N. High levels of C3c in the cerebrospinal fluid from amyotrophic lateral sclerosis patients. Acta Neurol Scand. 1985;72:61&#x2013;64. doi: 10.1111/j.1600-0404.1985.tb01548.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1985.tb01548.x</ArticleId><ArticleId IdType="pubmed">4050318</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolski S, Nikolic J, Bugarski-Prokopljevic C, Miletic V, Pavlovic S, Filipovic S. Serum and CSF immunological findings in ALS. Acta Neurol Scand. 1991;83:96&#x2013;98. doi: 10.1111/j.1600-0404.1991.tb04656.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1991.tb04656.x</ArticleId><ArticleId IdType="pubmed">2017904</ArticleId></ArticleIdList></Reference><Reference><Citation>Armulik A, Genove G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell. 2011;21:193&#x2013;215. doi: 10.1016/j.devcel.2011.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2011.07.001</ArticleId><ArticleId IdType="pubmed">21839917</ArticleId></ArticleIdList></Reference><Reference><Citation>Armulik A, Genove G, Mae M, Nisancioglu MH, Wallgard E, Niaudet C, He L, Norlin J, Lindblom P, Strittmatter K, et al. Pericytes regulate the blood-brain barrier. Nature. 2010;468:557&#x2013;561. doi: 10.1038/nature09522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09522</ArticleId><ArticleId IdType="pubmed">20944627</ArticleId></ArticleIdList></Reference><Reference><Citation>Barichello T, Pereira JS, Savi GD, Generoso JS, Cipriano AL, Silvestre C, Petronilho F, Dal-Pizzol F, Vilela MC, Teixeira AL. A kinetic study of the cytokine/chemokines levels and disruption of blood-brain barrier in infant rats after pneumococcal meningitis. J Neuroimmunol. 2011;233:12&#x2013;17. doi: 10.1016/j.jneuroim.2010.10.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2010.10.035</ArticleId><ArticleId IdType="pubmed">21109308</ArticleId></ArticleIdList></Reference><Reference><Citation>Behrens EM, Gadue P, Gong SY, Garrett S, Stein PL, Cohen PL. The mer receptor tyrosine kinase: expression and function suggest a role in innate immunity. Eur J Immunol. 2003;33:2160&#x2013;2167. doi: 10.1002/eji.200324076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200324076</ArticleId><ArticleId IdType="pubmed">12884290</ArticleId></ArticleIdList></Reference><Reference><Citation>Beuche W, Yushchenko M, Mader M, Maliszewska M, Felgenhauer K, Weber F. Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis. Neuroreport. 2000;11:3419&#x2013;3422. doi: 10.1097/00001756-200011090-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-200011090-00003</ArticleId><ArticleId IdType="pubmed">11095490</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, Corcia P, Pradat PF, Bocca C, Gordon PH, Veyrat-Durebex C, Mavel S, Nadal-Desbarats L, Moreau C, Devos D, et al. Metabolomics in cerebrospinal fluid of patients with amyotrophic lateral sclerosis: An untargeted approach via high-resolution mass spectrometry. J Proteome Res. 2013;12:3746&#x2013;3754. doi: 10.1021/pr400376e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr400376e</ArticleId><ArticleId IdType="pubmed">23859630</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Petzold A, Sussmuth SD, Ludolph AC, Tumani H. Axonal damage markers in cerebrospinal fluid are increased in ALS. Neurology. 2006;66:852&#x2013;856. doi: 10.1212/01.wnl.0000203120.85850.54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000203120.85850.54</ArticleId><ArticleId IdType="pubmed">16567701</ArticleId></ArticleIdList></Reference><Reference><Citation>Brkic M, Balusu S, Libert C, Vandenbroucke RE. Friends or foes: matrix Metalloproteinases and their multifaceted roles in neurodegenerative diseases. Mediat Inflamm. 2015;2015:620581. doi: 10.1155/2015/620581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/620581</ArticleId><ArticleId IdType="pmc">PMC4619970</ArticleId><ArticleId IdType="pubmed">26538832</ArticleId></ArticleIdList></Reference><Reference><Citation>Brkic M, Balusu S, Van Wonterghem E, Gorle N, Benilova I, Kremer A, Van Hove I, Moons L, De Strooper B, Kanazir Set al (2015) Amyloid beta oligomers disrupt blood-CSF barrier integrity by activating matrix Metalloproteinases. J Neurosci 35: 12766&#x2013;12778 Doi 10.1523/JNEUROSCI.0006-15.2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6795210</ArticleId><ArticleId IdType="pubmed">26377465</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai Q, He WQ, Zhou M, Lu H, Fu ZF. Enhancement of blood-brain barrier permeability and reduction of tight junction protein expression are modulated by chemokines/cytokines induced by rabies virus infection. J Virol. 2014;88:4698&#x2013;4710. doi: 10.1128/JVI.03149-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03149-13</ArticleId><ArticleId IdType="pmc">PMC3993813</ArticleId><ArticleId IdType="pubmed">24522913</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Li Q, Darrow AL, Wang Y, Derian CK, Yang J, de Garavilla L, Andrade-Gordon P, Damiano BP. Mer receptor tyrosine kinase signaling participates in platelet function. Arterioscler Thromb Vasc Biol. 2004;24:1118&#x2013;1123. doi: 10.1161/01.ATV.0000130662.30537.08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.0000130662.30537.08</ArticleId><ArticleId IdType="pubmed">15130911</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Bardes EE, Aronow BJ, Jegga AG. ToppGene suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 2009;37:W305&#x2013;W311. doi: 10.1093/nar/gkp427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkp427</ArticleId><ArticleId IdType="pmc">PMC2703978</ArticleId><ArticleId IdType="pubmed">19465376</ArticleId></ArticleIdList></Reference><Reference><Citation>Coatti GC, Frangini M, Valadares MC, Gomes JP, Lima NO, Cavacana N, Assoni AF, Pelatti MV, Birbrair A, de Lima ACP, et al. Pericytes extend survival of ALS SOD1 mice and induce the expression of antioxidant enzymes in the murine model and in IPSCs derived neuronal cells from an ALS patient. Stem Cell Rev Rep. 2017;13:686&#x2013;698. doi: 10.1007/s12015-017-9752-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-017-9752-2</ArticleId><ArticleId IdType="pubmed">28710685</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen PL, Caricchio R, Abraham V, Camenisch TD, Jennette JC, Roubey RA, Earp HS, Matsushima G, Reap EA. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med. 2002;196:135&#x2013;140. doi: 10.1084/jem.20012094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20012094</ArticleId><ArticleId IdType="pmc">PMC2194017</ArticleId><ArticleId IdType="pubmed">12093878</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins MA, An J, Hood BL, Conrads TP, Bowser RP. Label-free LC-MS/MS proteomic analysis of cerebrospinal fluid identifies protein/pathway alterations and candidate biomarkers for amyotrophic lateral sclerosis. J Proteome Res. 2015;14:4486&#x2013;4501. doi: 10.1021/acs.jproteome.5b00804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.5b00804</ArticleId><ArticleId IdType="pmc">PMC5592736</ArticleId><ArticleId IdType="pubmed">26401960</ArticleId></ArticleIdList></Reference><Reference><Citation>Daneman R, Zhou L, Kebede AA, Barres BA. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature. 2010;468:562&#x2013;566. doi: 10.1038/nature09513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09513</ArticleId><ArticleId IdType="pmc">PMC3241506</ArticleId><ArticleId IdType="pubmed">20944625</ArticleId></ArticleIdList></Reference><Reference><Citation>Demestre M, Parkin-Smith G, Petzold A, Pullen AH. The pro and the active form of matrix metalloproteinase-9 is increased in serum of patients with amyotrophic lateral sclerosis. J Neuroimmunol. 2005;159:146&#x2013;154. doi: 10.1016/j.jneuroim.2004.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2004.09.015</ArticleId><ArticleId IdType="pubmed">15652414</ArticleId></ArticleIdList></Reference><Reference><Citation>Dietrich MO, Spuch C, Antequera D, Rodal I, de Yebenes JG, Molina JA, Bermejo F, Carro E. Megalin mediates the transport of leptin across the blood-CSF barrier. Neurobiol Aging. 2008;29:902&#x2013;912. doi: 10.1016/j.neurobiolaging.2007.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2007.01.008</ArticleId><ArticleId IdType="pubmed">17324488</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnenfeld H, Kascsak RJ, Bartfeld H. Deposits of IgG and C3 in the spinal cord and motor cortex of ALS patients. J Neuroimmunol. 1984;6:51&#x2013;57. doi: 10.1016/0165-5728(84)90042-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-5728(84)90042-0</ArticleId><ArticleId IdType="pubmed">6368581</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudek SM, Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol (1985) 2001;91:1487&#x2013;1500. doi: 10.1152/jappl.2001.91.4.1487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.2001.91.4.1487</ArticleId><ArticleId IdType="pubmed">11568129</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang L, Huber-Abel F, Teuchert M, Hendrich C, Dorst J, Schattauer D, Zettlmeissel H, Wlaschek M, Scharffetter-Kochanek K, Tumani H, et al. Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS) J Neurol Sci. 2009;285:62&#x2013;66. doi: 10.1016/j.jns.2009.05.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2009.05.025</ArticleId><ArticleId IdType="pubmed">19523650</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraineau S, Monvoisin A, Clarhaut J, Talbot J, Simonneau C, Kanthou C, Kanse SM, Philippe M, Benzakour O. The vitamin K-dependent anticoagulant factor, protein S, inhibits multiple VEGF-A-induced angiogenesis events in a Mer- and SHP2-dependent manner. Blood. 2012;120:5073&#x2013;5083. doi: 10.1182/blood-2012-05-429183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2012-05-429183</ArticleId><ArticleId IdType="pubmed">23065156</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S, Hernandez-Ontiveros DG, Rodrigues MC, Haller E, Frisina-Deyo A, Mirtyl S, Sallot S, Saporta S, Borlongan CV, Sanberg PR. Impaired blood-brain/spinal cord barrier in ALS patients. Brain Res. 2012;1469:114&#x2013;128. doi: 10.1016/j.brainres.2012.05.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.05.056</ArticleId><ArticleId IdType="pubmed">22750125</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S, Sanberg PR. Blood-CNS barrier impairment in ALS patients versus an animal model. Front Cell Neurosci. 2014;8:21. doi: 10.3389/fncel.2014.00021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00021</ArticleId><ArticleId IdType="pmc">PMC3910123</ArticleId><ArticleId IdType="pubmed">24550780</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S, Saporta S, Haller E, Kolomey I, Bennett SP, Potter H, Sanberg PR (2007) Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS One 2: e1205.Doi: 10.1371/journal.pone.0001205</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2075163</ArticleId><ArticleId IdType="pubmed">18030339</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S, Woods RL, 3rd, Louis MK, Zesiewicz TA, Kuzmin-Nichols N, Sullivan KL, Miller AM, Hernandez-Ontiveros DG, Sanberg PR. Reduction of circulating endothelial cells in peripheral blood of ALS patients. PLoS One. 2010;5:e10614. doi: 10.1371/journal.pone.0010614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0010614</ArticleId><ArticleId IdType="pmc">PMC2868893</ArticleId><ArticleId IdType="pubmed">20485543</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghersi-Egea JF, Strazielle N, Catala M, Silva-Vargas V, Doetsch F, Engelhardt B. Molecular anatomy and functions of the choroidal blood-cerebrospinal fluid barrier in health and disease. Acta Neuropathol. 2018;135:337&#x2013;361. doi: 10.1007/s00401-018-1807-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1807-1</ArticleId><ArticleId IdType="pubmed">29368213</ArticleId></ArticleIdList></Reference><Reference><Citation>Guiloff RJ, McGregor B, Thompson E, Blackwood W, Paul E. Motor neurone disease with elevated cerebrospinal fluid protein. J Neurol Neurosurg Psychiatry. 1980;43:390&#x2013;396. doi: 10.1136/jnnp.43.5.390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.43.5.390</ArticleId><ArticleId IdType="pmc">PMC490564</ArticleId><ArticleId IdType="pubmed">7420088</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta PK, Prabhakar S, Sharma S, Anand A (2011) Vascular endothelial growth factor-a (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients. J Neuroinflammation 8. 10.1186/1742-2094-1188-1147</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3117705</ArticleId><ArticleId IdType="pubmed">21569455</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel JS, Beers DR, Wen S, Bowser R, Appel SH. Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS. Neurology. 2009;72:1614&#x2013;1616. doi: 10.1212/WNL.0b013e3181a41228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181a41228</ArticleId><ArticleId IdType="pubmed">19414730</ArticleId></ArticleIdList></Reference><Reference><Citation>Howangyin KY, Zlatanova I, Pinto C, Ngkelo A, Cochain C, Rouanet M, Vilar J, Lemitre M, Stockmann C, Fleischmann BK, et al. Myeloid-epithelial-reproductive receptor tyrosine kinase and Milk fat globule epidermal growth factor 8 coordinately improve remodeling after myocardial infarction via local delivery of vascular endothelial growth factor. Circulation. 2016;133:826&#x2013;839. doi: 10.1161/CIRCULATIONAHA.115.020857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.020857</ArticleId><ArticleId IdType="pmc">PMC4767109</ArticleId><ArticleId IdType="pubmed">26819373</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1&#x2013;13. doi: 10.1093/nar/gkn923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkn923</ArticleId><ArticleId IdType="pmc">PMC2615629</ArticleId><ArticleId IdType="pubmed">19033363</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen SF, van der Spek SJ, Ten Brink JB, Essing AH, Gorgels TG, van der Spek PJ, Jansonius NM, Bergen AA. Gene expression and functional annotation of the human and mouse choroid plexus epithelium. PLoS One. 2013;8:e83345. doi: 10.1371/journal.pone.0083345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0083345</ArticleId><ArticleId IdType="pmc">PMC3877019</ArticleId><ArticleId IdType="pubmed">24391755</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenne CN, Urrutia R, Kubes P. Platelets: bridging hemostasis, inflammation, and immunity. Int J Lab Hematol. 2013;35:254&#x2013;261. doi: 10.1111/ijlh.12084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijlh.12084</ArticleId><ArticleId IdType="pubmed">23590652</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings LK. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost. 2009;102:248&#x2013;257. doi: 10.1160/TH09-03-0192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH09-03-0192</ArticleId><ArticleId IdType="pubmed">19652875</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8:118&#x2013;127. doi: 10.1093/biostatistics/kxj037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biostatistics/kxj037</ArticleId><ArticleId IdType="pubmed">16632515</ArticleId></ArticleIdList></Reference><Reference><Citation>Kantari-Mimoun C, Castells M, Klose R, Meinecke AK, Lemberger UJ, Rautou PE, Pinot-Roussel H, Badoual C, Schrodter K, Osterreicher CH, et al. Resolution of liver fibrosis requires myeloid cell-driven sinusoidal angiogenesis. Hepatology. 2015;61:2042&#x2013;2055. doi: 10.1002/hep.27635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.27635</ArticleId><ArticleId IdType="pubmed">25475053</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur C, Rathnasamy G, Ling EA (2016) The choroid plexus in healthy and diseased brain. J Neuropathol Exp Neurol. 10.1093/jnen/nlv030</Citation><ArticleIdList><ArticleId IdType="pubmed">26888305</ArticleId></ArticleIdList></Reference><Reference><Citation>Kivisakk P, Mahad DJ, Callahan MK, Trebst C, Tucky B, Wei T, Wu L, Baekkevold ES, Lassmann H, Staugaitis SM, et al. Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc Natl Acad Sci U S A. 2003;100:8389&#x2013;8394. doi: 10.1073/pnas.1433000100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1433000100</ArticleId><ArticleId IdType="pmc">PMC166239</ArticleId><ArticleId IdType="pubmed">12829791</ArticleId></ArticleIdList></Reference><Reference><Citation>Kooij G, Kopplin K, Blasig R, Stuiver M, Koning N, Goverse G, van der Pol SM, van Het Hof B, Gollasch M, Drexhage JA, et al. Disturbed function of the blood-cerebrospinal fluid barrier aggravates neuro-inflammation. Acta Neuropathol. 2014;128:267&#x2013;277. doi: 10.1007/s00401-013-1227-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1227-1</ArticleId><ArticleId IdType="pubmed">24356983</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunis G, Baruch K, Miller O, Schwartz M. Immunization with a myelin-derived antigen activates the Brain's choroid plexus for recruitment of Immunoregulatory cells to the CNS and attenuates disease progression in a mouse model of ALS. J Neurosci. 2015;35:6381&#x2013;6393. doi: 10.1523/JNEUROSCI.3644-14.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3644-14.2015</ArticleId><ArticleId IdType="pmc">PMC6605216</ArticleId><ArticleId IdType="pubmed">25904790</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonardi A, Abbruzzese G, Arata L, Cocito L, Vische M. Cerebrospinal fluid (CSF) findings in amyotrophic lateral sclerosis. J Neurol. 1984;231:75&#x2013;78. doi: 10.1007/BF00313720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00313720</ArticleId><ArticleId IdType="pubmed">6737012</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Gao L, Zang D. Elevated levels of IFN-gamma in CSF and serum of patients with amyotrophic lateral sclerosis. PLoS One. 2015;10:e0136937. doi: 10.1371/journal.pone.0136937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0136937</ArticleId><ArticleId IdType="pmc">PMC4557946</ArticleId><ArticleId IdType="pubmed">26332465</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Shi GP. CD31: beyond a marker for endothelial cells. Cardiovasc Res. 2012;94:3&#x2013;5. doi: 10.1093/cvr/cvs108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvs108</ArticleId><ArticleId IdType="pubmed">22379038</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunetta C, Lizio A, Maestri E, Sansone VA, Mora G, Miller RG, Appel SH, Chio A. Serum C-reactive protein as a prognostic biomarker in amyotrophic lateral sclerosis. JAMA Neurol. 2017;74:660&#x2013;667. doi: 10.1001/jamaneurol.2016.6179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.6179</ArticleId><ArticleId IdType="pmc">PMC5822215</ArticleId><ArticleId IdType="pubmed">28384752</ArticleId></ArticleIdList></Reference><Reference><Citation>Marelli-Berg FM, Clement M, Mauro C, Caligiuri G. An immunologist's guide to CD31 function in T-cells. J Cell Sci. 2013;126:2343&#x2013;2352. doi: 10.1242/jcs.124099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.124099</ArticleId><ArticleId IdType="pubmed">23761922</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeker RB, Williams K, Killebrew DA, Hudson LC. Cell trafficking through the choroid plexus. Cell Adhes Migr. 2012;6:390&#x2013;396. doi: 10.4161/cam.21054.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cam.21054</ArticleId><ArticleId IdType="pmc">PMC3496674</ArticleId><ArticleId IdType="pubmed">22902764</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev. 2006;86:279&#x2013;367. doi: 10.1152/physrev.00012.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00012.2005</ArticleId><ArticleId IdType="pubmed">16371600</ArticleId></ArticleIdList></Reference><Reference><Citation>Mi H, Muruganujan A, Ebert D, Huang X, Thomas PD. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res. 2019;47:D419&#x2013;D426. doi: 10.1093/nar/gky1038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1038</ArticleId><ArticleId IdType="pmc">PMC6323939</ArticleId><ArticleId IdType="pubmed">30407594</ArticleId></ArticleIdList></Reference><Reference><Citation>Niebroj-Dobosz I, Janik P, Sokolowska B, Kwiecinski H. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Eur J Neurol. 2010;17:226&#x2013;231. doi: 10.1111/j.1468-1331.2009.02775.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2009.02775.x</ArticleId><ArticleId IdType="pubmed">19796283</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen CM, Dymecki SM. Sonic hedgehog is required for vascular outgrowth in the hindbrain choroid plexus. Dev Biol. 2010;340:430&#x2013;437. doi: 10.1016/j.ydbio.2010.01.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ydbio.2010.01.032</ArticleId><ArticleId IdType="pmc">PMC2897143</ArticleId><ArticleId IdType="pubmed">20123094</ArticleId></ArticleIdList></Reference><Reference><Citation>Peyvandi F, Garagiola I, Baronciani L. Role of von Willebrand factor in the haemostasis. Blood Transfus. 2011;9(Suppl 2):s3&#x2013;s8. doi: 10.2450/2011.002S.</Citation><ArticleIdList><ArticleId IdType="doi">10.2450/2011.002S</ArticleId><ArticleId IdType="pmc">PMC3159913</ArticleId><ArticleId IdType="pubmed">21839029</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirttila T, Vanhatalo S, Turpeinen U, Riikonen R. Cerebrospinal fluid insulin-like growth factor-1, insulin growth factor binding protein-2 or nitric oxide are not increased in MS or ALS. Acta Neurol Scand. 2004;109:337&#x2013;341. doi: 10.1111/j.1600-0404.2004.00223.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2004.00223.x</ArticleId><ArticleId IdType="pubmed">15080860</ArticleId></ArticleIdList></Reference><Reference><Citation>Privratsky JR, Newman PJ. PECAM-1: regulator of endothelial junctional integrity. Cell Tissue Res. 2014;355:607&#x2013;619. doi: 10.1007/s00441-013-1779-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-013-1779-3</ArticleId><ArticleId IdType="pmc">PMC3975704</ArticleId><ArticleId IdType="pubmed">24435645</ArticleId></ArticleIdList></Reference><Reference><Citation>Ransohoff RM, Engelhardt B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol. 2012;12:623&#x2013;635. doi: 10.1038/nri3265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3265</ArticleId><ArticleId IdType="pubmed">22903150</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J. Focality, stochasticity and neuroanatomic propagation in ALS pathogenesis. Exp Neurol. 2014;262(Pt B):121&#x2013;126. doi: 10.1016/j.expneurol.2014.07.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.07.021</ArticleId><ArticleId IdType="pubmed">25108067</ArticleId></ArticleIdList></Reference><Reference><Citation>Redzic ZB, Preston JE, Duncan JA, Chodobski A, Szmydynger-Chodobska J. The choroid plexus-cerebrospinal fluid system: from development to aging. Curr Top Dev Biol. 2005;71:1&#x2013;52. doi: 10.1016/S0070-2153(05)71001-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0070-2153(05)71001-2</ArticleId><ArticleId IdType="pubmed">16344101</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chio A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryberg H, An J, Darko S, Lustgarten JL, Jaffa M, Gopalakrishnan V, Lacomis D, Cudkowicz M, Bowser R. Discovery and verification of amyotrophic lateral sclerosis biomarkers by mass spectrometry based proteomics. Muscle Nerve. 2010;42:104&#x2013;111. doi: 10.1002/mus.21683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21683</ArticleId><ArticleId IdType="pmc">PMC2975276</ArticleId><ArticleId IdType="pubmed">20583124</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagare AP, Bell RD, Zhao Z, Ma Q, Winkler EA, Ramanathan A, Zlokovic BV. Pericyte loss influences Alzheimer-like neurodegeneration in mice. Nat Commun. 2013;4:2932. doi: 10.1038/ncomms3932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms3932</ArticleId><ArticleId IdType="pmc">PMC3945879</ArticleId><ArticleId IdType="pubmed">24336108</ArticleId></ArticleIdList></Reference><Reference><Citation>Serot JM, Bene MC, Faure GC. Choroid plexus, aging of the brain, and Alzheimer's disease. Front Biosci. 2003;8:s515&#x2013;s521. doi: 10.2741/1085.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/1085</ArticleId><ArticleId IdType="pubmed">12700093</ArticleId></ArticleIdList></Reference><Reference><Citation>Serot JM, Bene MC, Foliguet B, Faure GC. Morphological alterations of the choroid plexus in late-onset Alzheimer's disease. Acta Neuropathol. 2000;99:105&#x2013;108. doi: 10.1007/PL00007412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/PL00007412</ArticleId><ArticleId IdType="pubmed">10672315</ArticleId></ArticleIdList></Reference><Reference><Citation>Shechter R, London A, Schwartz M. Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates. Nat Rev Immunol. 2013;13:206&#x2013;218. doi: 10.1038/nri3391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3391</ArticleId><ArticleId IdType="pubmed">23435332</ArticleId></ArticleIdList></Reference><Reference><Citation>Shechter R, Miller O, Yovel G, Rosenzweig N, London A, Ruckh J, Kim KW, Klein E, Kalchenko V, Bendel P, et al. Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity. 2013;38:555&#x2013;569. doi: 10.1016/j.immuni.2013.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2013.02.012</ArticleId><ArticleId IdType="pmc">PMC4115271</ArticleId><ArticleId IdType="pubmed">23477737</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva-Vargas V, Maldonado-Soto AR, Mizrak D, Codega P, Doetsch F. Age-dependent niche signals from the choroid plexus regulate adult neural stem cells. Cell Stem Cell. 2016;19:643&#x2013;652. doi: 10.1016/j.stem.2016.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2016.06.013</ArticleId><ArticleId IdType="pubmed">27452173</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith R, Myers K, Ravits J, Bowser R. Amyotrophic lateral sclerosis: is the spinal fluid pathway involved in seeding and spread? Med Hypotheses. 2015;85:576&#x2013;583. doi: 10.1016/j.mehy.2015.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2015.07.014</ArticleId><ArticleId IdType="pubmed">26220261</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754. doi: 10.3389/fimmu.2018.00754.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00754</ArticleId><ArticleId IdType="pmc">PMC5908901</ArticleId><ArticleId IdType="pubmed">29706967</ArticleId></ArticleIdList></Reference><Reference><Citation>Stopa EG, Tanis KQ, Miller MC, Nikonova EV, Podtelezhnikov AA, Finney EM, Stone DJ, Camargo LM, Parker L, Verma A, et al. Comparative transcriptomics of choroid plexus in Alzheimer's disease, frontotemporal dementia and Huntington's disease: implications for CSF homeostasis. Fluids Barriers CNS. 2018;15:18. doi: 10.1186/s12987-018-0102-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-018-0102-9</ArticleId><ArticleId IdType="pmc">PMC5977762</ArticleId><ArticleId IdType="pubmed">29848382</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam OH, Rozhkov NV, Shaw R, Kim D, Hubbard I, Fennessey S, Propp N, Consortium NA, Fagegaltier D, Harris BT, et al. Postmortem cortex samples identify distinct molecular subtypes of ALS: Retrotransposon activation, oxidative stress, and activated glia. Cell Rep. 2019;29(1164&#x2013;1177):e1165. doi: 10.1016/j.celrep.2019.09.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.09.066</ArticleId><ArticleId IdType="pmc">PMC6866666</ArticleId><ArticleId IdType="pubmed">31665631</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner CA, Thompson RC, Bunney WE, Schatzberg AF, Barchas JD, Myers RM, Akil H, Watson SJ. Altered choroid plexus gene expression in major depressive disorder. Front Hum Neurosci. 2014;8:238. doi: 10.3389/fnhum.2014.00238.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2014.00238</ArticleId><ArticleId IdType="pmc">PMC4001046</ArticleId><ArticleId IdType="pubmed">24795602</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas T, Ugalde C, Spuch C, Antequera D, Moran MJ, Martin MA, Ferrer I, Bermejo-Pareja F, Carro E. Abeta accumulation in choroid plexus is associated with mitochondrial-induced apoptosis. Neurobiol Aging. 2010;31:1569&#x2013;1581. doi: 10.1016/j.neurobiolaging.2008.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2008.08.017</ArticleId><ArticleId IdType="pubmed">18838197</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen GY, Wisniewski HM, Kascsak RJ. Biondi ring tangles in the choroid plexus of Alzheimer's disease and normal aging brains: a quantitative study. Brain Res. 1999;832:40&#x2013;46. doi: 10.1016/s0006-8993(99)01466-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0006-8993(99)01466-3</ArticleId><ArticleId IdType="pubmed">10375650</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler EA, Bell RD, Zlokovic BV. Central nervous system pericytes in health and disease. Nat Neurosci. 2011;14:1398&#x2013;1405. doi: 10.1038/nn.2946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2946</ArticleId><ArticleId IdType="pmc">PMC4020628</ArticleId><ArticleId IdType="pubmed">22030551</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler EA, Sengillo JD, Sullivan JS, Henkel JS, Appel SH, Zlokovic BV. Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis. Acta Neuropathol. 2013;125:111&#x2013;120. doi: 10.1007/s00401-012-1039-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1039-8</ArticleId><ArticleId IdType="pmc">PMC3535352</ArticleId><ArticleId IdType="pubmed">22941226</ArticleId></ArticleIdList></Reference><Reference><Citation>Wuolikainen A, Jonsson P, Ahnlund M, Antti H, Marklund SL, Moritz T, Forsgren L, Andersen PM, Trupp M (2016) Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects. Mol Biosyst: Doi 10.1039/c5mb00711a</Citation><ArticleIdList><ArticleId IdType="pubmed">26883206</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun SH, Sim EH, Goh RY, Park JI, Han JY. Platelet activation: the mechanisms and potential biomarkers. Biomed Res Int. 2016;2016:9060143. doi: 10.1155/2016/9060143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/9060143</ArticleId><ArticleId IdType="pmc">PMC4925965</ArticleId><ArticleId IdType="pubmed">27403440</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, Zhou ZR, Che CH, Liu CY, He RL, Huang HP. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2017;88:540&#x2013;549. doi: 10.1136/jnnp-2016-315018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>